Evaluating the Efficacy and Safety of Two Doses of the Polyclonal Anti-Tumor Necrosis Factor-α Fragment Antibody AZD9773 in Adult Patients With Severe Sepsis and/or Septic Shock
Gordon R. Bernard(Vanderbilt University Medical Center), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Justin P.O. Lindemann(University Hospital Ostrava), Steven P. LaRosa(Eli Lilly (United States)), Nicola Schmitt(AstraZeneca (United Kingdom)), Wayne M. Dankner(University of California San Diego), James A. Russell(University of British Columbia), Bruno François(Inserm), Jean-Paul Mira(Sorbonne Paris Cité), Mitchell M. Levy(Brown University), R. Phillip Dellinger(Cooper Medical School of Rowan University), Jean‐Louis Vincent(Université Libre de Bruxelles)
Cited by 85
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k